Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2007
11/01/2007WO2007122173A1 Substituted pyrazinone derivatives for use as a medicine
11/01/2007WO2007121976A1 Spiro[benzopyran] or spiro[benzofuran] derivatives which inhibit the sigma receptor
11/01/2007WO2007121921A2 Purine derivatives for use as adenosin a2a receptor agonists
11/01/2007WO2007121687A1 4-methyl-1h-diaryl pyrazole derivatives and their uses as medicament
11/01/2007WO2007121523A1 Pharmaceutical compositions of oxcarbazepine with a median particle size of 15 to 30 microns
11/01/2007WO2007108936A3 N-substituted-azacyclylamines as histamine-3 antagonists
11/01/2007WO2007098967A3 Imidazole compounds having pharmaceutical activity towards the sigma receptor
11/01/2007WO2007093880A3 Novel pyrone-indole derivatives and process for their preparation
11/01/2007WO2007093519A3 Ibandronate regimen for treating metastatic bone pain
11/01/2007WO2007092379A3 Sesamol derivatives as novel inhibitors of arachidonic acid formation
11/01/2007WO2007088034A3 Tuberous sclerosis treatment
11/01/2007WO2007082561A3 Method for the treatment of tinnitus
11/01/2007WO2007072503A3 Combinations for managing inflammation and associated disorders
11/01/2007WO2007072092A3 New phenanthridine derivatives as bradykinin antagonists
11/01/2007WO2007068815A3 Heterocyclic derivatives, preparation and therapeutic use thereof
11/01/2007WO2007067617A3 Use of a cb1 antagonist for treating negative symptoms of schizophrenia
11/01/2007WO2007064972A3 Monoclonal antibodies against amyloid beta protein and uses thereof
11/01/2007WO2006136454A3 Use of inhibitors of n-methyl transferases for the therapy of parkinson's disease
11/01/2007WO2004062610A3 4',4''-SUBSTITUTED 3α-(DIPHENYLMETHOXY)TROPANE ANALOGS FOR TREATMENT OF MENTAL DISORDERS
11/01/2007WO2002090332A3 Novel aeylheteroalkylaminε derivatives
11/01/2007WO2002060471A3 Ligands for receptor-like protein tyrosine phosphatases
11/01/2007US20070255063 Benzothiazole- and benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors
11/01/2007US20070255061 5-Fluoro-, Chloro-and Cyano-Pyridin-2-Yl-Tetrazoles as Ligands of the Metabotropic Glutamate Receptor-5
11/01/2007US20070254958 by preventing the formation of insoluble beta-amyloid and arresting the production of beta-amyloid; e.g. 3-{2-[(5-aminopentyl)amino]-2-oxoethoxy}-5-({[(1R)-1-(4-fluorophenyl)ethyl]amino}carbonyl)phenyl phenylmethanesulfonate
11/01/2007US20070254954 Composition with Preventive or Improvement Effect on Symptoms or Disesases Associted with Stress-Induced Behavior Disorders
11/01/2007US20070254932 Drugs for Treating Duplication of Hypertension With Hyperuricemia and/or Hypercholesterolemia
11/01/2007US20070254929 Fluoro-and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof
11/01/2007US20070254921 Reducing activity of mutant of human cytochrome enzyme; Administering to individual in need of nicotine replacement therapy therapeutically effective amount of nicotine and methoxsalen, to enhance effectiveness
11/01/2007US20070254918 Dopamine-, Norepinephrine- and Serotonin- Transporter-Selective Heterocyclic Compounds and Their Therapeutic Applications
11/01/2007US20070254917 Intracellular receptor modulator compounds and methods
11/01/2007US20070254912 Benzimidazolyl-pyridine compounds for inflammation and immune-related uses
11/01/2007US20070254904 schizophrenia, emesis, anxiety and depression, irritable bowel syndrome (IBS), circadian rhythm disturbances, pre-eclampsia, nociception, neuropathic pain, pancreatitis, neurogenic inflammation, asthma, chronic obstructive pulmonary disease (COPD) and urinary incontinence
11/01/2007US20070254903 Novel Spiroindoline or Spiroisoquinoline Compounds, Methods of Use and Compositions Thereof
11/01/2007US20070254896 Substituted pyrimidine kinase inhibitors
11/01/2007US20070254890 4(Phenyl-Piperazinyl-Methyl) Benzamide Derivatives and Their Use for the Treatment of Pain or Gastrointestinal Disorders
11/01/2007US20070254889 noninvasive technique for imaging and quantitating amyloid deposits; 2-phenyl- imidazo [1,2,a] pyridine derivatives; radiolabelling; drug delivery; 2-(4'-dimethylaminophenyl)-6-iodobenzothiazole
11/01/2007US20070254876 Glucuronate salt of a piperazine compound
11/01/2007US20070254875 Androgen Receptor Modulator Compounds and Methods
11/01/2007US20070254871 Compounds for the Treatment of Inflammation of the Central Nervous System
11/01/2007US20070254866 Aminoquinolones as GSK-3 inhibitors
11/01/2007US20070254848 Algin Oligosaccharides and the Derivatives thereof as Well as the Manufacture and the Use of the Same
11/01/2007US20070254835 Composition and method for treating neurological disorders
11/01/2007US20070254364 Methods and compositions for treating disorders involving excitotoxicity
11/01/2007US20070254314 Methods of treating autism and autism spectrum disorders
11/01/2007US20070254312 Protein Kinase Inhibitors and Methods for Identiying Same
11/01/2007US20070254297 KCNQ2 and KCNQ3 - potassium channel genes which are mutated in Benign Familial Neonatal Convulsions (BFNC) and other epilepsies
11/01/2007US20070254028 Granules Comprising a Nsaid and a Sugar Alcohol Made by Melt Extrusion
11/01/2007US20070253950 Methods for Preventing and Treating Amyloidogenic Diseases
11/01/2007US20070253946 Axon Regeneration Promoter
11/01/2007US20070253934 New strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it
11/01/2007US20070253906 Identifying Amyloid precurser protein lowering agents; non-steroidal anti-inflammatory drug (NSAID); Alzheimer's disease
11/01/2007US20070253905 Abeta42 LOWERING AGENTS
11/01/2007CA2650006A1 Substituted biphenyl carboxylic acids and derivatives thereof
11/01/2007CA2649919A1 Phenyl-and pyridinyl amide inhibitors of c-fms kinase
11/01/2007CA2649845A1 Terphenyl derivatives for treatment of alzheimer' s disease
11/01/2007CA2649820A1 Agent for treating polyglutamine aggregation-caused disease or suppressing onset thereof
11/01/2007CA2649800A1 Hgf precursor protein variant and active protein thereof
11/01/2007CA2649628A1 Pharmaceutical product
11/01/2007CA2649272A1 Pharmaceutical composition for conformational disease
11/01/2007CA2649043A1 Azolecarboxamide derivative
11/01/2007CA2648813A1 Organic compounds
11/01/2007CA2647099A1 Therapeutic target molecules for the development of novel medicaments for degenerative diseases
11/01/2007CA2647077A1 Pyrazolo-tetrahydro pyridine derivatives as orexin receptor antagonists
11/01/2007CA2646652A1 Substituted pyrazinone derivatives for use as a medicine
11/01/2007CA2641139A1 Spiro[benzopyran] or spiro[benzofuran] derivatives which inhibit the sigma receptor
10/2007
10/31/2007EP1849801A1 Tyrosine-based motif and clostridial neurotoxins
10/31/2007EP1849785A1 N-(2-Thiazolyl)-amide derivatives as GSK-3 inhibitors
10/31/2007EP1849772A1 Bicyclic tetrahydropyrrole compounds
10/31/2007EP1849771A1 Bicyclic tetrahydropyrrole compounds
10/31/2007EP1849762A1 Substituted biphenyl carboxylic acids and derivatives thereof
10/31/2007EP1849760A1 Ether compounds, compositions, and uses thereof
10/31/2007EP1849469A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
10/31/2007EP1849462A2 A method of alleviating signs and symptons of Spasticity
10/31/2007EP1848708A1 Sulfamate and sulfamide derivatives for the treatment of epilepsy and related disorders
10/31/2007EP1848695A1 Compounds which potentiate glutamate receptor and uses thereof in medicine
10/31/2007EP1848692A1 AZOLYLACYLGUANIDINES AS ß-SECRETASE INHIBITORS
10/31/2007EP1848455A1 Use of calcitonin and calcitonin-like peptides to treat and prevent multiple sclerosis
10/31/2007EP1848453A1 Treatment for neurodegeneration
10/31/2007EP1848446A1 Use of iron(iii) complex compounds
10/31/2007EP1848426A2 Tricyclic cytoprotective compounds
10/31/2007EP1848420A2 Polymorphic forms of a gabaa agonist
10/31/2007EP1848415A1 Combination therapy with glatiramer acetate and rasagiline for the treatment of multiple sclerosis
10/31/2007EP1848275A1 Kappa opioid receptor ligands
10/31/2007EP1727539B1 Use of rotigotine for treating and preventing parkinson's plus syndrome
10/31/2007EP1636206B1 Imidazole derivatives as glutmate receptor antagonists
10/31/2007EP1537122B9 Antidepressant indolealkyl derivatives of heterocycle-fused benzodioxan methylamines
10/31/2007EP1531807A4 Bazedoxifene treatment regimens
10/31/2007EP1513821B1 Protein kinase inhibitors
10/31/2007EP1501533A4 Peptide inhibitors of protein kinase c-gamma for pain management
10/31/2007EP1448198B1 Nicotin-or isonicotin benzothiazole derivatives
10/31/2007EP1404331B1 Sustained release formulations of oxymorphone
10/31/2007EP1368301B1 Side-chain halogenated amino carboxylic acid derivatives as medicaments for treating cardiovascular diseases
10/31/2007EP1289993B1 Caspase inhibitors and uses thereof
10/31/2007EP1192247B9 Sphingosine kinase enzyme
10/31/2007EP1177312B1 Human gil-19/ae289 proteins and polynucleotides encoding same
10/31/2007EP1153013B1 5-ht1f agonists
10/31/2007EP1144384B1 Compounds which inhibit leukocyte adhesion mediated by vla-4
10/31/2007EP0910564B1 D-amino acid derived inhibitors of cysteine and serine proteases
10/31/2007DE102006019597A1 Spirocyclische Cyclohexan-Derivate Spirocyclic cyclohexane derivatives
10/31/2007DE102006019589A1 Inhibitoren des TASK-1 und Task-3 Ionenkanals Inhibitors of the TASK-1 and Task 3 ion channel
1 ... 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 ... 1833